An economic and environmentally friendly pen for GLP-1
Vision
Pre-filled, cartridge-based pull-push pen designed for multiple injections of a fixed dose. The pen is designed to support the growing needs in obesity management and related therapies.
What it offers
- Larger volume capability
Delivers doses of up to 1.0 mL—five times more than comparable models with similar handling mechanisms—making it ideal for higher-dose therapies
- Enhanced sustainability
Made from a single eco-material with low number of parts, aiming to reduce the environmental footprint
- Better usability
- Simple pull-push dosing mechanism
- No priming needed before first use
- Prevents dosing errors by means of visual and tactile feedback
- Active dose-stop function
Market background
With a strong focus on patient needs and ongoing advancements in obesity and metabolic therapies, YpsoDot is built to accommodate the next generation of medications—supporting better health outcomes through simple and intuitive delivery technology.
Current development phase and outlook*
The platform is advancing and development is progressing according to plan. Ypsomed is engaging in collaboration discussions with pharmaceutical partners interested in shaping upcoming program phases.
Interested in specific timelines for your project? Contact us to discuss partnership opportunities and tailored development schedules.
*Co-developments possible in different development phases.
